Abiraterone acetate is a semisynthetic steroid with multiple chiral centres figure 1, all of which are controlled so that abiraterone acetate is a single stereoisomer. Des discrete event simulation, aap abiraterone acetate in combination with prednisone. Each 250 mg tablet contains 189 mg of lactose and 6. You may not use the abiraterone acetate instant savings program if you are uninsured or have no prescription drug coverage for abiraterone acetate. The applicant requested the active substance abiraterone acetate contained in the above medicinal product to be considered as a new active substance in itself. Australian public assessment report for abiraterone acetate. Assessment report for zytiga abiraterone procedure no. Abiraterone acetate is a selective, irreversible inhibitor of cyp17, an enzyme that is critical in the. A study of abiraterone acetate plus lowdose prednisone.
Abiraterone acetate tablets definition abiraterone acetate tablets contain nlt 90. Pdf abiraterone acetate in castrationresistant prostate. Abiraterone acetate cb7630, cb 7630, cb7630 is an acetate salt form of abiraterone which is a steroidal cytochrome cyp17 inhibitor with ic50 of 72 nm. Check with your pharmacist if you have questions about the best way to throw out drugs. Zytiga is used to treat men with prostate cancer that has spread to other parts of the body it is not known if zytiga is safe and effective in females or children. Read the patient information leaflet if available from your pharmacist before you start taking abiraterone and each time you get a refill. Abiraterone acetate plus prednisolone improves survival in men with. Zytiga tablets contain either 250 mg or 500 mg of abiraterone acetate.
Abiraterone acetate in castrationresistant prostate cancer. Abiraterone acetate is a cyp17 inhibitor that is sold in 500 mg and 250 mg coated tablets and 250 mg uncoated tablets. Abiraterone zytiga, a novel agent for the management of. Abiraterone acetate zytiga macmillan cancer support. Specifically it is used together with corticosteroid for. Abiraterone acetate plus prednisone in patients with newly. Abiraterone acetate is designed to treat these tumors by inhibiting the production of androgen in the testes, adrenal glands, and prostate cancer tumors themselves. Optimal sequencing of enzalutamide and abiraterone acetate. Targets cyp17 ic50 72 nm 1 in vitro abiraterone shows a good complexation with the heme iron only in sm1. Do not flush down a toilet or pour down a drain unless you are told to do so.
Abiraterone acetate zytiga, janssen biotech is a new cytochrome p450 cyp 17 inhibitor that was approved by the fda in 2011 in combination with prednisone for crpc in patients who have received. Abiraterone acetate zytiga, janssen biotech is a new cytochrome p450 cyp 17 inhibitor that was approved by the fda in 2011 in combination with prednisone for crpc in patients who have received prior docetaxel chemotherapy. Studies were performed to assess the potential inhibition of cyp2c8 by abiraterone acetate, to characterise the mechanism by which resistance to abiraterone acetate is developed and to characterise impurity r601250. Abiraterone for prostate cancer not previously treated with. Zytiga abiraterone acetate tablets 1 highlights of. Abiraterone acetate aa, after metabolization to abiraterone, is an oral inhibitor of the cytochrome p450c17. Abiraterone acetate is a prodrug that is converted in vivo to abiraterone. See actual entry in rtecs for complete information. Abiraterone acetate abiraterone or zytiga is a hormonal therapy drug used to treat advanced prostate cancer. Antitumour activity and safety of enzalutamide in patients with metastatic castrationresistant prostate cancer previously treated with abiraterone acetate plus. It is also being studied in patients with earlierstage prostate cancer and in women with metastatic breast cancer. Check with your pharmacist if you have questions about the. Prescription treatment with zytiga abiraterone acetate. Abiraterone acetate for early stage metastatic prostate cancer.
Zytiga abiraterone acetate is a prescription medicine that is used along with prednisone. For both indications, patients take mg of abiraterone acetate once daily along with 5 mg of prednisone twice daily. It is given with steroid tablets and sometimes with other types of hormonal therapy drugs. It is best to read this information with our general information about hormonal therapies and the type of cancer you have. Abiraterone improves survival in metastatic prostate. Abiraterone acetate is rapidly hydrolyzed to abiraterone by esterases, then. Abiraterone acetate has been identified or labeled to communicate a risk of reproductive harm developmental, female, and male endpoints. These findings support the use of abiraterone acetate. Abiraterone presented as 500mg tablets since formulation switch in 2017. Abiraterone acetate in the treatment of metastatic castrationresistant. Only select registry of toxic effects of chemical substances rtecs data is presented here. Each tablet contains 250 mg of abiraterone acetate. Updated guidelines for metastatic hormonesensitive.
Abiraterone acetate for early stage metastatic prostate. The safety of these increased exposures when multiple doses of abiraterone acetate. Avoid coadministration with cyp2d6 substrates with a narrow therapeutic index. The combination of abiraterone acetate plus prednisone with adt was associated with significantly longer overall survival than placebos plus adt in men with newly diagnosed highrisk mcspc and had a manageable safety profile. Abiraterone acetate is converted in vivo to abiraterone, an androgen biosynthesis inhibitor, which inhibits 17.
Download pdf of prescribing information for abiraterone acetate. We evaluated whether abiraterone acetate, an inhibitor of androgen biosynthesis, prolongs overall survival among patients with. Zytiga pharmacokinetics absorption bioavailability. Abiraterone acetate tablets are a cyp17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castrationresistant prostate cancer crpc. Abiraterone acetate is a selective, irreversible inhibitor of cyp17, an enzyme that is critical in the production of androgens in the testes, adrenal glands, and prostatetumor tissue. Abiraterone acetate is converted, in vivo, to abiraterone. Pdf abiraterone and increased survival in metastatic prostate. Updated guidelines for metastatic hormonesensitive prostate cancer. Abiraterone for prostate cancer not previously treated. Zytiga in combination with prednisone is indicated for the treatment of patients with metastatic castrationresistant prostate cancer crpc who have received. Highlights of prescribing information these highlights do.
458 553 1223 303 1231 1345 1267 238 595 1537 81 59 1101 188 1258 1006 688 391 1532 742 869 632 1556 1413 695 205 1350 122 841 342 345 113 2 837 687 1463 709 300 1495 864 1023 277 1045